Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Steve Usdin at BioCentury sent along a reprint of the newsletter's annual "Back to School" issue from last month in response to my note about "micropharma" the other day. And it's clear that he's been thinking along the same lines. Full Article at In the Pipeline